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Orotidine 5’-monophosphate decarboxylase (ODC- 
ase) has been  overexpressed  in  yeast  15C  cells  trans- 
formed  with a plasmid carrying  the URA3 gene  that 
encodes ODCase. Twenty g of cells having ODCase 
activity  equal  to 30 mg of pure enzyme  per  liter of cell 
culture  were  obtained  after 9 h of galactose  induction. 
To  remove  yeast  proteases, a 60-90s ammonium  sul- 
fate  fractionation  step  plus  the  addition of EDTA as an 
inhibitor of metallopeptidases  was  necessary.  The pu- 
rification protocol  yielded ODCase that  was protease- 
free  and  stable  to  storage  at 4 “C for 16 months. The 
pure enzyme  had a specific activity of 40 units/mg  in 
50 mM phosphate  buffer,  pH 6, and could  be stored  at 
-20 “C in  20%  glycerol  with  retention of full  activity 
for more than 2 years. The enzyme had a K,,, for 
orotidine 5’-monophosphate of 0.7 p~ at pH 6 and 
25 “C. The molecular weight of the  plasmid-derived 
ODCase monomer determined by electrophoresis on 
denaturing  polyacrylamide  gels  was  29,500. ODCase 
sedimented through sucrose density gradients as a 
monomer of about 30 kDa  at low protein  concentration 
and  in  the  absence of ligands  that  bind at the  catalytic 
site. An increase in the sedimentation rate could be 
induced  by increasing  the ODCase concentration or by 
adding  ligands that  are competitive  inhibitors. ODCase 
sedimented in a single  band  typical of a protein of 46 
kDa  at  the highest  protein  concentration  studied or  in 
the presence of 50 mM phosphate or 933 pM substrate 
(orotidine  5’-monophosphate) or product  (UMP). A di- 
mer  sedimenting as a protein of about 64 kDa  occurred 
in  the  presence of 50 p~ 6-azauridine 5’-monophos- 
phate  or 2 p~ 1-(5’-phospho-~-~-ribofuranosyl) 
barbituric  acid,  competitive  inhibitors of ODCase. 
These  results  resemble  the  ligand-induced  subunit as- 
sociation of the ODCase domain of bifunctional  UMP 
synthase and support the use of yeast ODCase as a 
model for ODCases from  other species. 
Conversion of orotidine  5’-monophosphate  (OMP)’  to  uri- 
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dine  5’-monophosphate  (UMP),  the  last  step  in  the de nouo 
pyrimidine  biosynthetic  pathway,  is catalyzed by orotidine  5’- 
monophosphate decarboxylase  (ODCase, EC 4.1.1.23). In 
mammals ODCase is  part of the  bifunctional  protein,  UMP 
synthase, which also  contains  the preceeding enzymatic  activ- 
ity in the  pathway,  orotate phosphoribosyltransferase (1). The 
deduced amino acid  sequence of yeast ODCase ( 2 )  shares 53- 
54% homology with  the sequence of the ODCase domain of 
mouse (3)  and  human (4) UMP synthases, which are  them- 
selves 90% identical. In addition, the deduced amino acid 
sequences of ODCases  from  several other species share several 
well conserved  regions with  yeast ODCase (5). 
In  the 1970’s ODCase was purified from commercial  bakers’ 
yeast by several  groups (6-8). The  amount of ODCase  in crude 
yeast  extracts  is  small,  and  therefore, large, bulky prepara- 
tions were required to  obtain  pure  protein.  The  purification 
described  by  Brody and  Westheimer  (6) yielded 15 mg  of pure 
ODCase  from  12 pounds of pressed  bakers’  yeast  using a  large 
(400 ml)  affinity  column  and two additional column chroma- 
tography  steps.  Such laborious purification  schemes  to  pre- 
pare ODCase  from  commercial yeast made obtaining the 
hundreds of milligrams of ODCase  required  for structural  and 
mechanistic  studies involving crystallography  and  NMR spec- 
troscopy  forbidding. 
In 1987 Lue et al. (9)  constructed a  vector  for  overexpression 
of URA3, the gene which  codes for yeast ODCase. This 
plasmid,  pGU2,  carries  the URA3 gene under  control of the 
promoter for GALl,  along with a region of the 2-micron 
plasmid needed for maintenance of the plasmid at  high copy 
number in yeast, and the GAL4 gene which codes for the 
GAL4 protein  (9).  The GAL4 protein  promotes  transcription 
from the promoter for GALl in response to galactose (lo), 
thus allowing the  expression of plasmid-derived proteins  to 
be induced by adding galactose to  the growth  medium. Work- 
ers  in Roger Kornberg’s group (9) reported yields of 30 mg of 
ODCase per  liter of yeast  culture  with a single purification 
step  using  yeast  strain Sf657-2D transformed with plasmid 
pGU2. 
We have  utilized plasmid  pGU2  to optimize  expression  of 
ODCase in a similar  yeast  strain, 15C, which was supplied  to 
us by the  Kornberg  laboratory. Modifications to  the published 
protocols  for  purification of yeast ODCase (6,9) were essential 
in  order  to  eliminate  protease  activities so that large amounts 
of highly pure,  stable ODCase  could be obtained. 
Both  the conserved amino acid  sequence and  the availabil- 
ity of large amounts of pure enzyme make  yeast ODCase an 
ideal model for studying the structure and mechanism of 
ODCases. In reports from this laboratory, yeast ODCase 
purified by the  protocol described herein  has been  crystallized 
for structural  studies (11) and used in catalytic mechanism 
studies of the  binding of a I3C-labeled inhibitor  using  NMR 
spectroscopy ( la) ,  as well as  in  kinetic  studies of “’C isotope 
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effects  (13). In  this  report we present  details of the overex- 
pression, purification, and characterization of plasmid-de- 
rived ODCase. Its  structural  and  kinetic  properties  are  com- 
pared  with  those  reported  for ODCase  purified  from  commer- 
cial bakers'  yeast. In  addition, we examine  the  sedimentation 
of yeast ODCase in sucrose gradients  and  compare  the effects 
of ligands in promoting different aggregation states of the 
enzyme with  those observed  for UMP  synthase (14-16). 
RESULTS AND DISCUSSION* 
Overexpression of Yeast ODCase-We obtained plasmid 
pGU2  and  yeast  strain 15C from Andrew Buchman  in Roger 
Kornberg's laboratory, who informed us  that  they  no longer 
used strain Sf657-2D for  overexpression of ODCase. There- 
fore,  modifications to  their published  procedure for overex- 
pression of yeast ODCase  from strain Sf657-2D cells carrying 
the pGU2 plasmid (9)  were  necessary to  obtain a high level 
of ODCase expression in  yeast  strain 15C. Using the published 
protocol (9),  yeast 15C cells grew poorly in  unsupplemented 
YP medium reaching an  OD660nm of only 1.5 instead of 4 as 
was reported  for Sf657-2D cells, and only a slight  increase  in 
the  total ODCase activity occurred when cells grown in  un- 
supplemented  YP medium were harvested  after 2  h of galac- 
tose induction (Table  I). 
Our  improved  protocol  included addition of  2% sucrose to 
the  YP medium  for the  initial growth of the cells and  induc- 
tion with  galactose for 9 instead of 2 h. With  these modifica- 
tions  yeast 15C cells grew to OD660.m of  2.53 in YP medium 
plus 2%  sucrose prior  to galactose induction,  with a 2.6-fold 
increase in  the cell wet weight when  compared to growth in 
YP medium without sucrose (Table I). Harvesting cells after 
9 h of galactose induction yielded an increase in the total 
ODCase activity of 4.4-fold in cells grown in YP medium 
without sucrose and 6.8-fold in cells grown in YP medium 
plus 2%  sucrose,  compared with  the  activity  in cells grown in 
YP medium without sucrose  which  were harvested  after only 
2 h of galactose induction  (Table I). The observed increase 
was due to an increase in both the total protein and the 
amount of ODCase. Our modified protocol  typically yielded 
18-22 g of cells (wet weight) and ODCase activity  equal  to 
about 30 mg of pure ODCase per  liter of YP medium, as was 
reported for Sf657-2D cells transformed  with  plasmid  pGU2 
(9). 
Purification and Stabilization of ODCase-We found  that 
the ODCase protein overexpressed  from plasmid pGU2,  when 
purified  by  previous  protocols (6, 9), was  highly  susceptible 
to proteolysis after  storage  for  as  little as 1 month at 4 "C 
(Fig. 1). These ODCase preparations  contained high levels of 
protease activities, which completely  destroyed the ODCase 
activity after 2 months of storage at 4 "C. Since we were 
interested in  crystallizing the enzyme and  conducting mech- 
anism  studies  (both of which  could require  that  the enzyme 
be  kept for long periods a t  4 "C  or  higher  temperatures),  it 
was necessary to stabilize the enzyme against proteolysis so 
as to  maintain  an active,  homogeneous protein  preparation. 
In  order  to design a strategy for removing proteases, we 
first  determined which of the  three classes of yeast  protease 
activities, distinguished by their pH optima (17, 18), were 
present a t  each  step  in  the purification  protocol. When  PMSF, 
pepstatin A, and  leupeptin were used as  protease  inhibitors 
' Portions of this paper (including "Experimental Procedures," part 
of "Results," Tables I and 11, Footnote 3, and Figs. 1 and 3-6) are 
presented in miniprint at the  end of this paper. Miniprint is easily 
read with the aid of a standard magnifying glass. Full size photocopies 
are included in the microfilm edition of the Journal that is available 
from  Waverly Press. 
as was done by Lue et al. (9),  the cell lysate still  contained 
significant  amounts of basic and  neutral  protease activities. 
These two  classes of protease  activities include proteinase B 
and carboxypeptidase Y, both  neutral proteases, as well as a 
number of metallopeptidases which are either neutral or 
slightly  basic proteases (17). Yeast  strain 15C contains  apep4 
mutation, which makes  it deficient in  both  proteinase B  (19) 
and carboxypeptidase Y (20). Therefore, we reasoned that 
metallopeptidases  might comprise  a  significant portion of the 
residual protease  activity  in  the enzyme preparations. Adding 
2 mM EDTA in addition to the other protease inhibitors 
reduced the  neutral  protease activity  measured in cell lysates 
by 70-75%. Including  an  ammonium  sulfate  precipitation  step 
and collecting the 60-90% precipitated protein completely 
eliminated  the  remaining  neutral  and b sic protease activities, 
as well as the  small  amount of residual  acidic protease activity. 
The purified  ODCase contained  no measurable protease ac- 
tivity  and was stable  against proteolysis  when stored for up 
to  16  months  at 4  "C (cf. Fig. 2, lane 12 with Fig. 1, lane 4 ) .  
We have added 2 mM EDTA  to  the  protease  inhibitor  mixture 
containing 1 mM PMSF, 1 PM pepstatin A, and 0.6 pM 
leupeptin  and have  routinely  added this  mixture  to  each buffer 
solution used during  the ODCase  purification. 
Yeast ODCase  overexpressed  from  plasmid pGU2 was pu- 
rified to homogeneity in  three purification steps  (Table I1 and 
Fig. 2). The CM-52 cellulose column removed a small  amount 
of contaminating  proteins  remaining  after  elution from the 
Affi-Gel Blue  column (cf. Fig. 1, lunes 1 and 2). In a typical 
purification, about 60 mg of ODCase  with a specific activity 
of  39-43 units/mg  (at 25 "C in  phosphate buffer, pH 6) or 70- 
80 units/mg  (at 37 "C in Tris-HC1 buffer, pH 7.4) was ob- 
tained from 4.8 liters of cell culture with  a recovery of 30- 
40% (Table 11). Recovery is  dependent  on  the  binding capacity 
of the Affi-Gel Blue  column,  which diminishes with  repeated 
use. The specific activity a t   pH 6 is  consistent  with  the 35- 
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FIG. 2. Purification of ODCase from  yeast  strain 15C cells 
transformed  with pGU2. Fractions from each purification step 
were run on  a 12% SDS-polyacrylamide gel and silver-stained. The 
puslLlull uf 111e dye r w I x  is 111dlca~ed by ~11e ur~uwhrud. L u r w  I ,  
molecular weight markers; lane 2, clarified cell lysate (4 pg); lane 3, 
clarified cell lysate + 2 mM EDTA (4 pg); lanes 4 and 5, resuspended 
ammonium sulfate fraction (2.5 and 4 pg); lanes 6 and 7, Affi-Gel 
Blue column eluate (0.4 pg); lane 8, CM-52 cellulose column effluent 
(0.4 pg); lanes 9-11, YMlO concentrate (0.75, 0.5, and 0.25 pg);  lane 
12, pure  ODCase stored for 16 months  at 4 "C (1 pg). 
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40 units/mg  reported for other  yeast  purifications (6, 9).  The 
pure ODCase  monomer had a  molecular mass of 29,500 dal- 
tons  as  estimated from its  migration  on a 12% SDS-polyacryl- 
amide gel (Fig. 2, lanes 9-12). This value is close to  the 29,000 
daltons  reported by Lue et al. (9)  and is consistent  with  the 
value of 29,200 calculated for the  amino acid  sequence  deduced 
from the nucleotide sequence of the URA3 gene (2). This 
value is higher than  the 27,500 reported by  Brody and  Westh- 
eimer  (6) for  ODCase  purified  from  commercial bakers’ yeast. 
While  this difference  may  reflect  a variation  in  the molecular 
weight standards  used for estimating  the weight of the  OD- 
Case monomer on  SDS-polyacrylamide gels, we suspect  that 
the difference  could  also be due to  proteolysis of the enzyme 
prepared from autolyzed commercial bakers’ yeast without 
the  addition of protease  inhibitors  (6). 
Subunit Association Studies-Previous studies of ODCase 
purified from commercial bakers’  yeast  have  indicated  that 
the enzyme exists  in  its  native  state  as a simple  dimer of 51 
kDa (8). In contrast, a monomer and dimer form of the 
ODCase domain of mouse UMP  synthase expressed in  yeast 
cells have been reported (14). Studies of bifunctional UMP 
synthase isolated from mouse Ehrlich  ascites cells have  estab- 
lished that this UMP synthase can exist in three distinct 
conformational forms: a 3.6 S monomer, a 5.1 S simple  dimer, 
and a 5.6 S dense  dimer (15, 16). The aggregation states were 
identified by sedimentation of UMP  synthase  through  sucrose 
gradients  containing  various  ligands  that  bind  to  the enzyme. 
Data from these  studies allowed Traut  et al. (16) to suggest 
that a  simple dimer,  the 5.1 S species, is produced  by  ligand 
binding  to  the ODCase catalytic  site  and  that  formation of a 
dense  dimer,  the 5.6 S species, is  promoted by effector binding 
to  a noncatalytic, regulatory site. 
In  order  to  investigate  the  subunit  association  and aggre- 
gation  state of yeast ODCase, the  protein was subjected to  
centrifugation  through 5-20% sucrose density  gradients  under 
a variety of experimental conditions. The effects of phosphate 
and enzyme concentration on the sedimentation of yeast 
ODCase were first  examined  in  order to  determine  optimal 
conditions for studying  the effect of nucleotide ligands  on  the 
subunit association of ODCase. We observed that ODCase 
stored  in 50 mM sodium phosphate buffer migrated  through 
sucrose gradients at  a molecular mass  intermediate  to  that 
expected for a monomer (29.5 kDa)  or a dimer (59 kDa). A 
similar effect of orthophosphate  on  the  sedimentation of UMP 
synthase  has  been  attributed  to  the  rapid  equilibration of the 
monomer  and dimer forms of the enzyme (15). When  protein 
from  an  ammonium  sulfate  precipitation  step (ODCase spe- 
cific activity = 15  units/mg) was  loaded onto a  sucrose gra- 
dient in the  amount of 10, 50, or 200 pg (equivalent  to  about 
2,  10, and 40 pg of pure  ODCase), a single  ODCase activity 
peak was observed  in  each gradient. The  apparent molecular 
masses of ODCase  in gradients loaded with  the  three  protein 
concentrations were 29, 36, and 46 kDa, respectively. We 
attribute this change in apparent mass to an equilibrium 
between the monomer and  dimer  forms of ODCase  induced 
by  a mass action effect as the ODCase concentration is 
increased. In  order  to  eliminate  the effects that  protein  con- 
centration  and  phosphate  have  on  the aggr gation and  subunit 
association of yeast ODCase, sucrose  gradients  to  determine 
the effect of nucleotide ligands were run  using a small  amount 
of pure ODCase that  had been  dialyzed against  Tris buffer. 
When  pure ODCase (2.2 pg) was sedimented  through a 5- 
20% sucrose gradient  in  the  absence of any nucleotide, OD- 
Case migrated as a  monomer of about 30 kDa (Fig. 3). Under 
identical  conditions, ODCase sedimented  as a dimer of about 
64  kDa  in a gradient  containing  either 50 p~ aza-UMP  or 2 
p~ BMP (Fig.  3). Gradients  containing  either  OMP  or  UMP 
at a concentration of 933 p~ both yielded an ODCase activity 
peak at a position  in  the  gradient  corresponding  to a molecular 
mass of 46 kDa, which is intermediate between the monomer 
and  dimer (Fig.  3). Since  the ODCase activity loaded onto  the 
gradient was sufficient  to  consume  all of the  OMP  present 
during  the course of the  40-h  centrifugation,  this  intermediate 
species  probably resulted  from  binding of UMP  to  ODCase in 
both cases. 
In summary, changes in the aggregation and/or subunit 
association  state of yeast ODCase can  be influenced by protein 
concentration, phosphate, and nucleotide ligands. Two dis- 
tinct species of the  yeast ODCase were identified a  30-kDa 
monomer observed at  low enzyme concentration  in  the  ab- 
sence of phosphate  and  other ligands, and a 64-kDa  dimer 
observed in  the  presence of aza-UMP  or  BMP. 
Based  on gel filtration  and sucrose density  gradient  studies, 
the  native  state of ODCase purified  from commercial  bakers’ 
yeast was considered to  be a dimer of 51 kDa (8). The  fact 
that a monomer of the  yeast ODCase in  solution  had  not been 
observed  previously can  be  explained  in  light of our  results, 
which suggest that  the  51-kDa species of ODCase probably 
corresponds  to  the 46-kDa intermediate observed  in the  pres- 
ence of UMP,  phosphate,  or at high protein  concentration. 
The previous protocol (8) used phosphate buffer during  the 
purification  and sucrose density  gradient  centrifugation, 
which can cause ODCase to migrate a t  a higher apparent 
molecular  mass. Also, the  protein  concentrations used during 
sucrose gradient  centrifugation  and gel exclusion chromatog- 
raphy could have  been  sufficient  to  promote  subunit associa- 
tion.  In  each of the  subsequent  purifications of yeast ODCase 
(6, 9, 21) in which aza-UMP was used to  elute  the enzyme 
from  affinity  columns,  no  attempt was  made to remove  resid- 
ual  aza-UMP  from  the enzyme. As we have shown,  a substan- 
tial  amount of the  inhibitor  remains  bound  to  the enzyme and 
must  be removed  by sequential dialysis  (see Fig. 4 and  “Re- 
sults” in Miniprint). Therefore, in these cases the residual 
bound  aza-UMP may  have been sufficient to  promote  subunit 
association of the enzyme and preclude observation of the 
monomer  form of ODCase. 
Changes  in  the  subunit  association of yeast ODCase in  the 
presence of ligands that bind to the catalytic site of the 
enzyme are very similar to those reported for the ODCase 
domain (14) and the intact UMP synthase (15, 16) from 
mouse. Such  changes  in  the aggregation state of multisubunit 
enzymes  have  been suggested as a means of regulating enzy- 
matic  activity  (22).  Indeed,  Traut  et al. (16) have  hypothesized 
that  the 5.6 S dense  dimer is promoted by effector binding  to 
a regulatory site and is the only form which has ODCase 
activity. While we have observed both a monomer  and a dimer 
form of yeast ODCase, we have no evidence for a species 
equivalent  to  the  dense  dimer species  observed in  UMP  syn- 
thase.  In  this  respect,  yeast ODCase  more closely resembles 
the  isolated ODCase domain of the  bifunctional mouse UMP 
synthase. 
Results in this report have shown that  properties of the 
plasmid-derived ODCase are very similar to those of the 
enzyme prepared  from commercial  bakers’  yeast. In  addition, 
our  results have  shown that  yeast ODCase closely resembles 
the ODCase domain of UMP  synthase  in  its  subunit associa- 
tion properties, thus adding to kinetic and sequence data 
which support  its use as a  model  for ODCases. Therefore, cell 
extracts containing the plasmid-derived yeast ODCase are 
excellent sources for obtaining large quantities of pure enzyme 
for studies  on  the  structure  and  mechanism of ODCases. 
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